Venture Life Group Plc (VLG):製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Venture Life Group Plc (VLG) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C8126
◆発行会社(調査会社):GlobalData
◆発行日:2018年10月
◆ページ数:21
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:イギリス
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Venture Life Group Plc (Venture Life) is a consumer goods company that offers ageing population products. The groups product and pipeline comprise food supplements for lowering cholesterol and maintaining brain function, medical devices for improving minor aches and pains, dry eyes and itchy skin and dermo-cosmetics for addressing the signs of ageing. It also provides cardiovascular products, dermatology products, neurology products, oral healthcare products, proctology products, and women’s healthcare products, among others. Venture Life offers development and manufacturing services to companies in the medical device and cosmetic sectors. The group also conducts research in the therapeutic areas of dermatology, cardiovascular, neurology, rheumatology, and ophthalmology. It markets its products in the UK and abroad. Venture Life is headquartered in Bracknell, the UK.

Venture Life Group Plc (VLG) – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Venture Life Group Plc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Venture Life Group Plc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Venture Life Group Plc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Venture Life Group Plc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Venture Life Group Plc, Medical Devices Deals, 2012 to YTD 2018 9
Venture Life Group Plc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Venture Life Group Plc, Pharmaceuticals & Healthcare, Deal Details 11
Partnerships 11
OptiBiotix Health Enters into an Agreement with Venture Life 11
Venture Life Enters into Distribution Agreement with DEEF Pharma 12
Venture Life Enters into Distribution Agreement with Hikma Pharma 13
Venture Life Enters into Distribution Agreement with Pharma Deen 14
Equity Offering 15
Venture Life Group Raises USD9 Million in IPO 15
Acquisition 16
Venture Life Group Acquires Biokosmes 16
Venture Life Group Plc – Key Competitors 17
Venture Life Group Plc – Key Employees 18
Venture Life Group Plc – Locations And Subsidiaries 19
Head Office 19
Other Locations & Subsidiaries 19
Recent Developments 20
Corporate Communications 20
Sep 20, 2018: Venture Life Group appoints Carl Dempsey as a Non-Executive Director 20
Appendix 21
Methodology 21
About GlobalData 21
Contact Us 21
Disclaimer 21

List of Tables
Venture Life Group Plc, Pharmaceuticals & Healthcare, Key Facts, 2017 2
Venture Life Group Plc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Venture Life Group Plc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Venture Life Group Plc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Venture Life Group Plc, Deals By Therapy Area, 2012 to YTD 2018 8
Venture Life Group Plc, Medical Devices Deals, 2012 to YTD 2018 9
Venture Life Group Plc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
OptiBiotix Health Enters into an Agreement with Venture Life 11
Venture Life Enters into Distribution Agreement with DEEF Pharma 12
Venture Life Enters into Distribution Agreement with Hikma Pharma 13
Venture Life Enters into Distribution Agreement with Pharma Deen 14
Venture Life Group Raises USD9 Million in IPO 15
Venture Life Group Acquires Biokosmes 16
Venture Life Group Plc, Key Competitors 17
Venture Life Group Plc, Key Employees 18
Venture Life Group Plc, Subsidiaries 19

List of Figures
Venture Life Group Plc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Venture Life Group Plc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Venture Life Group Plc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Venture Life Group Plc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Venture Life Group Plc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Venture Life Group Plc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Venture Life Group Plc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Venture Life Group Plc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Venture Life Group Plc, Medical Devices Deals, 2012 to YTD 2018 9

★海外企業調査レポート[Venture Life Group Plc (VLG):製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Daiwa House Industry Co., Ltd.:企業の戦略・SWOT・財務分析
    Daiwa House Industry Co., Ltd. - Strategy, SWOT and Corporate Finance Report Summary Daiwa House Industry Co., Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product a …
  • Xencor, Inc.:企業のM&A・事業提携・投資動向
    Xencor, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Xencor, Inc. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, …
  • IMI plc:企業の戦略・SWOT・財務情報
    IMI plc - Strategy, SWOT and Corporate Finance Report Summary IMI plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, pr …
  • CNX Resources Corp (CNX):企業の財務・戦略的SWOT分析
    CNX Resources Corp (CNX) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Meiji Holdings Co, Ltd.:戦略・SWOT・企業財務分析
    Meiji Holdings Co, Ltd. - Strategy, SWOT and Corporate Finance Report Summary Meiji Holdings Co, Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • Inflection Biosciences Ltd:製薬・医療:M&Aディール及び事業提携情報
    Summary Inflection Biosciences Ltd (Inflection Biosciences) is a drug development company focused on discovery and development of small molecule therapeutics for the treatment of cancer. The company’s pipeline products include dual mechanism kinase inhibitors and pim kinase inhibitors including IBL- …
  • Pharmaxis Ltd (PXS)-医療機器分野:企業M&A・提携分析
    Summary Pharmaxis Ltd (Pharmaxis) is a pharmaceutical research company that develops and commercialize healthcare products. The company offers products such as aridol which identify twitchy and assist in diagnosing and managing asthma, and bronchitol which restores normal lung hydration, improves lu …
  • MDxHealth SA (MDXH):医療機器:M&Aディール及び事業提携情報
    Summary MDxHealth SA (MDxHealth) develops and commercializes advanced epigenetic and other molecular tests for cancer assessment and the personalized treatment of patients. The company’s products portfolio includes ConfirmMDx, which detects absence or presence of prostate cancer; SelectMDx for prost …
  • Zurich Insurance Group Ltd:企業のM&A・事業提携・投資動向
    Zurich Insurance Group Ltd - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Zurich Insurance Group Ltd Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acqui …
  • Alabama Municipal Electric Authority:電力:M&Aディール及び事業提携情報
    Summary Alabama Municipal Electric Authority (AMEA) is a not-for-profit publicly-owned electric utility that generates, procures, and supplies power. The authority generates electricity from sources such as gas and solar. AMEA procures electricity from open market and South Carolina Public Service A …
  • CellaVision AB (CEVI):企業の財務・戦略的SWOT分析
    CellaVision AB (CEVI) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Hyposwiss Private Bank Geneve SA:企業の戦略・SWOT・財務情報
    Hyposwiss Private Bank Geneve SA - Strategy, SWOT and Corporate Finance Report Summary Hyposwiss Private Bank Geneve SA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, produ …
  • BioDelivery Sciences International Inc (BDSI):企業の財務・戦略的SWOT分析
    BioDelivery Sciences International Inc (BDSI) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key stre …
  • BFS Group Limited:企業の戦略・SWOT・財務情報
    BFS Group Limited - Strategy, SWOT and Corporate Finance Report Summary BFS Group Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • Ora Gold Ltd (THX):企業の財務・戦略的SWOT分析
    Summary Ora Gold Ltd (Ora Gold) is a mining and mineral exploration company. The company acquires, explores and develops lead, zinc, silver, nickel, graphite, copper, gold and uranium prospects in Western Australia and the Northern Territory. Its projects include Red Bore Copper-Gold Project, Garden …
  • MS&AD Insurance Group Holdings, Inc.:企業のM&A・事業提携・投資動向
    MS&AD Insurance Group Holdings, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's MS&AD Insurance Group Holdings, Inc. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports …
  • Wartsila Corp (WRT1V):電力:M&Aディール及び事業提携情報
    Summary Wartsila Corp (Wartsila) is a mechanical or industrial engineering company. It offers smart technologies and complete lifecycle solutions. Through sustainable innovation, total efficiency, and data analytics, the company harnesses the environmental and economic performance of the vessels and …
  • Stanwell Corporation Ltd:発電所・企業SWOT分析
    Stanwell Corporation Ltd - Power Plants and SWOT Analysis, 2017 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information on key empl …
  • Sumitomo Electric Industries Ltd (5802):電力:M&Aディール及び事業提携情報
    Summary Sumitomo Electric Industries Ltd (Sumitomo) is a manufacturing company that develops, manufactures, and sells various products related to electronics, info communications, automotive, industrial materials, and environment and energy. The company’s product portfolio includes wiring harnesses, …
  • Riverbed Technology, Inc.:企業の戦略的SWOT分析
    Riverbed Technology, Inc. - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆